首页> 外文OA文献 >Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a Murine tumor model

【2h】

Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a Murine tumor model

机译：高度减毒改性疫苗病毒Ankara（MVA）作为有效的重组载体：鼠肿瘤模型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Miles W. Carroll; Willem W. Overwijk; Ronald S. Chamberlain; Steven A. Rosenberg; Bernard Moss; Nicholas P. Restifo;
展开▼
作者单位

展开▼
年度 1997
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV. [J] . Rompay K. K. A. van, Abel K., Earl P., Vaccine . 2010,第6期

机译：病毒载体，初免-加强型SIV疫苗在婴儿恒河猴中的免疫原性：与减毒活病毒SIV相比，减毒水疱性口炎病毒（VSV）和改良牛痘安卡拉（MVA）重组SIV疫苗。
2. Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression [J] . Krupa Magdalena, Canamero Marta, Gomez Carmen E., Vaccine . 2011,第7期

机译：用重组DNA和修饰的牛痘病毒安卡拉（MVA）载体免疫，可传递PSCA和STEAP1抗原，可抑制前列腺癌的进展
3. Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa. [J] . Jaoko W, Nakwagala FN, Anzala O, Vaccine . 2008,第22期

机译：由重组质粒pTHr DNA或修饰的牛痘病毒安卡拉（MVA）载体在东非人类体内重组低剂量HIV-1 A候选疫苗的安全性和免疫原性。
4. Vectorization in an Oncolytic Vaccinia Virus of Antibodies Against Programmed Cell Death -1 (PD-1) Allows Their Intratumoral Delivery and an Improved Tumor-Growth Inhibition [C] . Jean-Baptiste March, Patricia Kleinpeter, Laetitia Fend, Protein Engineering Summit. . 2018

机译：矢量化在抗体抗体的抗体疫苗病毒中，针对编程的细胞死亡-1（PD-1）允许其肿瘤内递送和改善的肿瘤生长抑制
5. Effects of Modified Vaccinia Virus Ankara Expressing Mesothelin and the Poxvirus Immunoregulatory A35R gene in the Treatment of Murine Pancreatic Cancer [D] . Freistaedter, Andrew 2012

机译：表达间皮素和痘病毒免疫调节性A35R基因的痘苗病毒安卡拉对小鼠胰腺癌的治疗作用
6. Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a Murine tumor model [O] . Miles W. Carroll, Willem W. Overwijk, Ronald S. Chamberlain, -1

机译：高度减毒的改良痘苗病毒安卡拉（MVA）作为有效的重组载体：鼠肿瘤模型
7. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: Attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV [O] . Koen K.A. Van Rompay, Kristina Abel, Patricia Earl, 2010

机译：病毒载体的免疫原性，婴幼儿绵羊猕猴的Prime-Boost SIV疫苗方案：与活化的SIV相比，减毒的脉湿性口炎病毒（VSV）和改性痘苗的Ankara（MVA）重组SIV疫苗
8. Evaluation of the Efficacy of Modified Vaccinia Ankara (MVA)/IMVAMUNE (registered trademark) Against Aerosolized Rabbitpox Virus in a Rabbit Model [R] . Garza, N. L., Hatkin, J. M., Livingston, V., 2009

机译：改良痘苗剂安卡拉（mVa）/ ImVamUNE（注册商标）对兔模型气雾化兔痘病毒的疗效评价

Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a Murine tumor model

著录项

引文网络

相似文献

相关主题

期刊订阅